Bile acid nuclear receptor FXR and digestive system diseases.
Ding L, Yang L, Wang Z, Huang W.
Acta Pharm Sin B. 2015 Mar;5(2):135-44. doi: 10.1016/j.apsb.2015.01.004. Epub 2015 Feb 25.
Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.
Yuan SN, Wang MX, Han JL, Feng CY, Wang M, Wang M, Sun JY, Li NY, Simal-Gandara J, Liu C.
Phytomedicine. 2023 Apr;112:154702. doi: 10.1016/j.phymed.2023.154702. Epub 2023 Feb 4.
Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.
Lu ZH, Ding Y, Wang YJ, Chen C, Yao XR, Yuan XM, Bu F, Bao H, Dong YW, Zhou Q, Li L, Chen T, Li Y, Zhou JY, Wang Q, Shi GP, Jiang F, Chen YG.
J Ethnopharmacol. 2024 Oct 28;333:118260. doi: 10.1016/j.jep.2024.118260. Epub 2024 Apr 27.
Metabolomics study of dietary Pleurotus eryngii beta-type glycosidic polysaccharide on colitis induced by dextran sodium sulfate in mice - Exploration for the potential metabolic indicators in urine and serum.
Ma G, Tao Q, Li X, Han Y, Du H, Hu Q, Xiao H.
Food Chem. 2024 Nov 15;458:140195. doi: 10.1016/j.foodchem.2024.140195. Epub 2024 Jun 24.
Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis.
Xie D, Li F, Pang D, Zhao S, Zhang M, Ren Z, Geng C, Wang C, Wei N, Jiang P.
J Inflamm Res. 2021 Jul 2;14:2941-2953. doi: 10.2147/JIR.S313374. eCollection 2021.
Metabolomics reveals the potential metabolic mechanism of infliximab against DSS-induced acute and chronic ulcerative colitis.
Zhong G, Shi R, Chen Q, Zheng Y, Fan X, Sun Y, Wang S, Li M.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8815-8824. doi: 10.1007/s00210-024-03201-9. Epub 2024 Jun 7.
MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis.
Bondue T, Khodaparast L, Khodaparast L, Cairoli S, Goffredo BM, Gijsbers R, van den Heuvel L, Levtchenko E.
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F981-F987. doi: 10.1152/ajprenal.00014.2024. Epub 2024 Mar 28.
Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer.
Wang M, Ma Y, Yu G, Zeng B, Yang W, Huang C, Dong Y, Tang B, Wu Z.
Biomed Pharmacother. 2024 Oct;179:117292. doi: 10.1016/j.biopha.2024.117292. Epub 2024 Aug 15.
Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development.
Kang ZR, Jiang S, Han JX, Gao Y, Xie Y, Chen J, Liu Q, Yu J, Zhao X, Hong J, Chen H, Chen YX, Chen H, Fang JY.
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166941. doi: 10.1016/j.bbadis.2023.166941. Epub 2023 Nov 4.
The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium-induced colitis mice: effects of curcumin.
Zhou F, Mai T, Wang Z, Zeng Z, Shi J, Zhang F, Kong N, Jiang H, Guo L, Xu M, Lin J.
J Gastroenterol Hepatol. 2023 Aug;38(8):1333-1345. doi: 10.1111/jgh.16205. Epub 2023 May 20.
